Suppr超能文献

上呼吸道和消化道13-顺式维甲酸化学预防的进展:MD安德森癌症中心的经验

Evolution of aerodigestive tract 13-cis-retinoid acid chemoprevention: the M.D. Anderson experience.

作者信息

Hong W K, Benner S E, Lippman S M

机构信息

Department of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

出版信息

Leukemia. 1994;8 Suppl 3:S33-7.

PMID:7808022
Abstract

The ultimate goal of our chemoprevention research is to prevent or inhibit the development of aerodigestive cancer in humans. We have made substantial progress from our trials 10 years ago. The chemopreventive strategies utilized in our clinical trials involve the use of retinoids and carotenoids as chemopreventive agents. The choice of these agents was based upon their important anticarcinogenic and differentiation properties. It is important to understand how retinoids interact with cells to carry out their modulating activities, and we hope to increase our understanding through molecular analysis of retinoid receptors. In the case of aerodigestive epithelial tissues at risk, normal, non-keratinizing epithelial cells often express inappropriate squamous differentiation. Retinoids are thought to suppress premalignant lesions by suppressing these inappropriate squamous differentiation pathways. The role of retinoids in suppressing squamous differentiation markers and reversing premalignant lesions will be elucidated from this retinoid project. The development of a fundamental understanding of tumorigenesis in the aerodigestive tract can lead to novel preventive approaches. A relative degree of risk for cancer development in individuals depends on several components, including the extent of carcinogenic exposure, inherent sensitivity of the individual to carcinogens, the individual's nutritional status, etc. Individuals with a genetic component of increased carcinogen sensitivity appear to be at increased risk for developing primary and secondary tumors. Our chemoprevention research program is designed to develop innovative strategies for aerodigestive tract epithelial cancer prevention. The strength of our program is to bridge the gap between fundamental and cellular molecular studies in clinical chemoprevention trials. The outcome of our research efforts may have an enormous impact on public health in controlling aerodigestive epithelial cancers and other epithelial cancers as well.

摘要

我们化学预防研究的最终目标是预防或抑制人类气消化道癌症的发生。自10年前开展试验以来,我们已取得了重大进展。我们在临床试验中采用的化学预防策略包括使用视黄醇类和类胡萝卜素作为化学预防剂。选择这些药剂是基于它们重要的抗癌和分化特性。了解视黄醇类如何与细胞相互作用以发挥其调节活性非常重要,我们希望通过对视黄醇类受体的分子分析来加深理解。对于处于风险中的气消化道上皮组织而言,正常的非角化上皮细胞常常表现出不适当的鳞状分化。视黄醇类被认为可通过抑制这些不适当的鳞状分化途径来抑制癌前病变。该视黄醇类项目将阐明视黄醇类在抑制鳞状分化标志物和逆转癌前病变方面的作用。对气消化道肿瘤发生形成基本认识有助于开发新的预防方法。个体患癌风险的相对程度取决于几个因素,包括致癌暴露的程度、个体对致癌物的固有敏感性、个体的营养状况等。具有致癌物敏感性增加遗传成分的个体似乎患原发性和继发性肿瘤的风险更高。我们的化学预防研究项目旨在开发气消化道上皮癌预防的创新策略。我们项目的优势在于弥合临床化学预防试验中基础研究与细胞分子研究之间的差距。我们研究工作的成果可能对控制气消化道上皮癌及其他上皮癌的公共卫生产生巨大影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验